主动吸烟对胸腹及复杂腹主动脉瘤FB-EVAR围术期结局的影响
单中心回顾性分析2007至2023年676例择期FB-EVAR患者,比较主动吸烟者、既往吸烟者与从不吸烟者的围术期结局。结果显示吸烟状态与任何特定围术期不良事件无显著关联,主动吸烟不应视为择期FB-EVAR的禁忌证。
要点
- 主动吸烟者较既往和从不吸烟者更年轻,COPD和PAD比例更高。
- 吸烟状态与围术期死亡及主要不良事件无显著统计学关联。
- 解剖合适且整体优化的主动吸烟者不应因吸烟状态推迟FB-EVAR。
核心结论
- 主动吸烟状态似乎不影响复杂主动脉瘤FB-EVAR的围术期结局。
- 尽管应强烈鼓励戒烟,但不应因主动吸烟状态而推迟修复手术。
研究设计与样本
- 单中心回顾性 review,纳入2007至2023年择期FB-EVAR治疗TAAA和CAAAs的患者。
- 共676例患者,分为主动吸烟者141例(21%)、既往吸烟者455例(67%)和从不吸烟者80例(12%)。
- 手术前6周内戒烟者被视为主动吸烟者,排除破裂和有症状动脉瘤。
主要发现
- 主动吸烟者显著年轻于既往和从不吸烟者(71±6.7、75±6.9、76±12岁,P<.001)。
- 主动吸烟者COPD(60% vs 42% vs 6.2%,P<.001)和PAD(31% vs 24% vs 10%,P=.002)比例显著更高。
- 从不吸烟者extent II动脉瘤比例显著高于既往和主动吸烟者(34% vs 18% vs 15%,P=.001)。
- 单因素和多因素logistic回归分析显示吸烟状态与任何特定围术期不良事件无显著统计学关联。
关键数值与推荐
- 主动吸烟者141例(21%),既往吸烟者455例(67%),从不吸烟者80例(12%)。
- 主动吸烟者平均年龄71±6.7岁,既往吸烟者75±6.9岁,从不吸烟者76±12岁(P<.001)。
- 主动吸烟者COPD比例60%,既往吸烟者42%,从不吸烟者6.2%(P<.001)。
- 主动吸烟者PAD比例31%,既往吸烟者24%,从不吸烟者10%(P=.002)。
临床怎么用
- 解剖合适且整体优化的患者,主动吸烟不应单独视为择期FB-EVAR的禁忌证。
- 对主动吸烟者行FB-EVAR似乎不损害早期安全性或手术有效性。
- 仍应强烈鼓励患者戒烟。
局限性
- 单中心回顾性研究设计。
- 主动吸烟者样本量相对较小(141例)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The aim of this study was to evaluate outcomes of fenestrated-branched endovascular aortic repair (FB-EVAR) of thoracoabdominal aortic aneurysms (TAAAs) and complex abdominal aortic aneurysms (CAAAs) in patients actively smoking at the time of repair compared with previous smokers and non-smokers. METHODS: Single-center retrospective review of elective FB-EVARs for TAAA and CAAAs between 2007 and 2023 was conducted. Demographics, comorbidities, aneurysm extent/ morphology, technical details, and peri-operative outcomes were collected. Patients were grouped into 1 of 3 groups: active smokers, prior smokers, and never smokers. Patients who stopped smoking within 6 weeks to surgery were considered active smokers. Rupture and symptomatic aneurysms were excluded. Endpoints included early (<30 days) mortality and major adverse events (MAEs). RESULTS: There were 676 patients (73% male, mean age 74 ± 7.8). There were 141 (21%) active smokers, 455 (67%) prior smokers, and 80 (12%) never smokers. Active smokers were significantly younger than prior or never smokers (71 ± 6.7, 75 ± 6.9, and 76 ± 12, respectively; P < .001). Cardiovascular risk factors were similar, except active smokers were significantly more likely to have chronic obstructive pulmonary disease (60% vs 42% vs 6.2%, P < .001) and peripheral arterial disease (31% vs 24% vs 10%, P = .002) when compared to prior and never smokers, respectively. Patients who never smoked had significantly more extent II aneurysms (34%) than prior (18%) and active (15%) smokers, P = .001. Univariable and multivariable logistic regression analyses showed no statistically significant associations between smoking status and any specific peri-operative adverse events following surgery. CONCLUSION: Active smoking status does not appear to affect peri-operative outcomes after FB-EVAR for complex aortic aneurysms. Although smoking cessation must be strongly encouraged, repair should not be delayed due to active smoking status.Clinical ImpactThese data suggest that active smoking, in isolation, should not be considered a contraindication to elective FB-EVAR when anatomy is suitable and patients are otherswise optimized. This is particularly relevant for high-risk patients who may have limited alternative treatment options. Proceeding with FB-EVAR in active smokers does not appear to compromise early safety or procedural efficacy.
引用
- Rodrigues DVS, Rogers RT, Chait J, et al. Impact of Active Smoking in Peri-operative Outcomes of Patients Undergoing FB-EVAR for Thoracoabdominal and Complex Abdominal Aortic Aneurysms. J Endovasc Ther. 2026. PMID: 42773082. doi:10.1177/15266028261484740
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。